// App-Quantinova.ai

: Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors — a Retrospective Study By the EBMT Chronic Malignancies Working Party

Researchers

Presenter

  • Aleksandar Radujkovic

Principal Investigators

  • Arnon Nagler

  • Francis Ayuketang Ayuk

  • Jrgen Finke

  • Johanna Tischer

  • Jiri Mayer

  • Koc Yener

  • Federica SORA

  • Jakob R. Passweg

  • Jennifer Byrne

  • Pavel Jindra

  • Hendrik Veelken

  • Grard Soci

  • Johan Maertens

  • Nicolaas Schaap

  • Arnold Ganser

  • Maija Itl-Remes

  • Eleni Tholouli

  • Mutlu Arat

  • Vanderson G. Rocha

  • Per Ljungman

  • Yves Chalandon

  • Kroger Nicolaus

Medical Centers

  • Dept. of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany

  • EBMT Data Office Leiden,, Leiden,, Netherlands

  • Division of Hematology and Bone Marrow Transplantation, The Chaim Sheba Medical Center, Tel-Hashomer, Ramat-Gan , Israel

  • Department of Stem Cell Transplantation, University Medical Center Hamburg, Hamburg,

  • Department of Hematology, Oncology and Stem Cell Transplantation, Uniklinik Freiburg, Freiburg, Germany

  • Ludwig-Maximilians-University Hospital of Munich-Grosshadern, Department of Internal Medicine III, Hematopoietic Cell Transplantation, Munich, Germany

  • Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic

  • Stem Cell Transplant Unit, Medical Park Hospitals, Antalya, Turkey

  • Hematology, Universit Cattolica del Sacro Cuore - Policlinico A. Gemelli, Roma, Italy

  • University Hospital, Hematology, Basel, Switzerland, Basel, Switzerland

  • Centre for Clinical Haematology, Nottingham University Hospital, Nottingham, United Kingdom

  • Charles University Hospital, Plzen, CZE

  • Department of Urology, Leiden Unviersity Medical Center, Leiden, Netherlands

  • Department of Hematology and Transplantation Unit, APHP Saint Louis Hospital, Paris, France

  • University Hospital Gasthuisberg, Leuven, Belgium

  • Radboud University Medical Centre, Nijmegen, Israel

  • Dept. Hematology, Hemostaseology, Oncology & Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

  • HUCH Comprehensive Cancer Center, Stem Cell Transplantation Unit,Helsinki,Finland

  • Manchester Royal Infirmary, Manchester, United Kingdom

  • Metropolitan Florence Nightingale Hospital, Istanbul, Turkey

  • Hospital Sirio-Libanes, Sao Paulo, Brazil, sao paulo, Brazil

  • Departments of Hematology and Cellular Therapy/Allogeneic Stem Cell Transplantation, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden

  • Département d’Oncologie, Service d’Hématologie, Hôpitaux Universitaires de Genève, Geneva, Switzerland

  • Department of Stem Cell Transplantation, University Hospital Eppendorf, Bone Marrow Transplantation Centre, Hamburg, Germany, Hamburg, Germany

Locations

  • Germany

  • Netherlands

  • Israel

  • Czech Republic

  • Turkey

  • Italy

  • Switzerland

  • France

  • Belgium

  • Finland

  • United Kingdom

  • Brazil

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Myelogenous Leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Estrogen receptor alpha

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved